e-learning
resources
Stockholm 2002
Monday 16.09.2002
COPD - general -2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The experiment and clinical study of ambroxol against the airway inflammation of chronic hypoxic rat and patients with COPD
X. Jin, H. Zhang (Beijing, China)
Source:
Annual Congress 2002 - COPD - general -2
Session:
COPD - general -2
Session type:
Thematic Poster Session
Number:
1658
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Jin, H. Zhang (Beijing, China). The experiment and clinical study of ambroxol against the airway inflammation of chronic hypoxic rat and patients with COPD. Eur Respir J 2002; 20: Suppl. 38, 1658
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Effect of 3-week pulmonary rehabilitation on airway inflammation in patients with chronic obstructive lung diseases
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018
A comparison of three different methods for analysing airway resistance in healthy subjects, asthma and chronic obstructive pulmonary disease patients
Source: Eur Respir J 2007; 30: Suppl. 51, 177s
Year: 2007
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Differential response of COPD bronchial epithelium to LPS in a three-dimensional culture model
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Source: Eur Respir J 2007; 29: 906-913
Year: 2007
Characterization and effects of bronchial colonization and inflammation in stable COPD patients. PAC-COPD study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006
On relationship between local and systemic chronic inflammation and between level of hypoxia and bronchial obstruction in COPD pts
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Systemic and airway inflammation and the presence of emphysema in patients with COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
Smoking and airway inflammation in asymptomatic subjects and in patients with chronic airway disease
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002
Pharmacological characterisation of indacaterol (QAB149), a novel once-daily inhaled β
2
-agonist, on small airways in human and rat lung slices
Source: Annual Congress 2006 - Novel treatments for asthma
Year: 2006
Gender effect on airway and lung parenchyma remodelling in an experimental model of chronic allergic asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept